Peter M. Hecht
2019 - Cyclerion Therapeutics
In 2019, Peter M. Hecht earned a total compensation of $121.6K as Chief Executive Officer at Cyclerion Therapeutics.
Compensation breakdown
| Option Awards | $48,900 |
|---|---|
| Salary | $71,154 |
| Other | $1,574 |
| Total | $121,628 |
Hecht received $71.2K in salary, accounting for 59% of the total pay in 2019.
Hecht also received $48.9K in option awards and $1.6K in other compensation.
Rankings
In 2019, Peter M. Hecht's compensation ranked 13,728th out of 13,971 executives tracked by ExecPay. In other words, Hecht earned more than 1.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 13,728 out of 13,971 | 2nd |
Division Manufacturing | 5,606 out of 5,701 | 2nd |
Major group Chemicals And Allied Products | 2,171 out of 2,200 | 1st |
Industry group Drugs | 1,860 out of 1,886 | 1st |
Industry Pharmaceutical Preparations | 1,380 out of 1,398 | 1st |
Source: SEC filing on April 28, 2021.
Hecht's colleagues
We found one more compensation record of an executive who worked with Peter M. Hecht at Cyclerion Therapeutics in 2019.
2019
Andreas Busch
Cyclerion Therapeutics
Chief Scientific Officer
News
Cyclerion Therapeutics COO Cheryl Gault's 2022 pay slips 3% to $645K
April 3, 2023
Cyclerion Therapeutics CSO Andreas Busch's 2021 pay slips 3% to $783K
April 26, 2022
Cyclerion Therapeutics CSO Andreas Busch's 2020 pay falls 75% to $807K
April 28, 2021
Ironwood Pharmaceuticals CEO Mark Mallon receives $10M in 2019
April 21, 2020
Ironwood Pharmaceuticals CEO Peter Hecht's 2018 pay slips 14% to $5.2M
April 26, 2019